Clinical significance of flowcytometric minimal residual disease detection in pediatric acute myeloid leukemia patients treated according to the DCOG ANLL97/MRC AML12 protocol
2010; Springer Nature; Volume: 24; Issue: 9 Linguagem: Inglês
10.1038/leu.2010.153
ISSN1476-5551
AutoresVincent H. J. van der Velden, A van der Sluijs-Geling, B Gibson, Jeroen G. te Marvelde, Patricia G. Hoogeveen, Wim C.J. Hop, Keith Wheatley, Marc Bierings, Gerrit‐Jan Schuurhuis, Siebold S.N. de Graaf, Elisabeth R. van Wering, Jacques J. M. van Dongen,
Tópico(s)Neutropenia and Cancer Infections
Referência(s)